PARNF — Parnell Pharmaceuticals Holdings Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $1.44m
- $11.71m
- AU$13.17m
Annual cashflow statement for Parnell Pharmaceuticals Holdings, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2012 June 30th | 2013 June 30th | 2014 June 30th | 2015 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Changes in Working Capital | 0.027 | 0.007 | 0.024 | 0.009 |
Other Operating Cash Flow | ||||
Cash from Operating Activities | 3.56 | -2.98 | -11.5 | -16.4 |
Capital Expenditures | -5.21 | -2.96 | -1.92 | -9.55 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | 0 | 0.544 | 1.44 | 1.67 |
Sale of Fixed Assets | ||||
Change in Net Investments | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -5.21 | -2.41 | -0.483 | -7.88 |
Financing Cash Flow Items | -0.68 | -0.68 | -5.11 | 0 |
Other Financing Cash Flow | ||||
Total Cash Dividends Paid | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 1.01 | 6.17 | 31.9 | 12.1 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | -0.645 | 0.781 | 19.9 | -10.2 |